Arbutus Biopharma Corp (ABUS) — Cash Flow Quality Index
Arbutus Biopharma Corp (ABUS) has a Cash Flow Quality Index of -0.05x as of March 2026. Operating cash flow of $-8.11 Million is below net income of $169.69 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore how efficiently does Arbutus Biopharma Corp generate cash to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Arbutus Biopharma Corp Cash Flow Quality Index (2006–2012)
Historical Cash Flow Quality Index for Arbutus Biopharma Corp across 2 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check total reinvestment intensity of Arbutus Biopharma Corp to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Arbutus Biopharma Corp (2006–2012)
Year-by-year earnings quality comparison for Arbutus Biopharma Corp. For live market cap and the full company financial profile, see Arbutus Biopharma Corp (ABUS) market capitalisation.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2012 | 1.11x | $33.27 Million | $29.95 Million | ▲ +865.7% |
| 2006 | -0.15x | $-2.62 Million | $18.08 Million | — |